This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

InTech Partners With The American Society For Exosomes And Microvesicles To Publish Exosomes And Microvesicles Journal, An Open Access Publication





RIJEKA, Croatia, April 8, 2013 /PRNewswire/ -- InTech Open Access publisher is pleased to announce the collaboration with the American Society for Exosomes and Microvesicles (ASEMV) to publish the scientific journal Exosomes and Microvesicles, a peer-reviewed publication designed to bring together exosomes principles, scientific research and clinical applications. The Exosomes and Microvesicles journal is one of the first publications to focus exclusively on this subject matter, which has important implications for treating diseases such as cancer.

Despite the past decade's explosion of research within the fields of exosomes, microvesicles and other extracellular vesicles, access to this data is often limited – thus impacting further advancements in human health. As the official journal of the ASEMV, Exosomes and Microvesicles will provide open access to global data, supporting the organization's mission to advance extracellular vesicle research and support the scientists, institutions and laboratories working in this field.

"The goal of Exosomes and Microvesicles is to connect scientists, clinicians and industry-based researchers, enhancing the translation of exosomes and their biology into clinical trials," said Douglas Taylor, ASEMV Secretary-General and Exosomes and Microvesicles editor. "No other current journal focuses on the application of exosomes in the maintenance of health and development of disease."

Exosomes and Microvesicles editors include experts and leaders in these research fields, who provide peer-review for all data submitted to the journal. Exosomes and Microvesicles' promise of excellence is evident in its Associate Editors and members of its Editorial Board: international experts with diverse expertise mirroring the journal's scope. Editors include:

  • Stephen J. Gould , ASEMV Acting President, Johns Hopkins University, Baltimore, USA
  • Douglas Taylor , ASEMV Secretary-General, Louisville, USA
  • Winston Patrick Kuo , Harvard Medical School, Boston, USA
  • Antonio Chiesi , Exosomics Siena SpA, Siena, Italy

Exosomes and Microvesicles will provide global access to high-impact research with novel contributions to the growing body of data around exosomes, microvesicles and other secreted vesicles. All accepted papers will undergo peer review and will be published in an open-access electronic format, with no charge to journal readers.

"As part of the launch of Exosomes and Microvesicles, InTech and ASEMV are currently waiving all submission fees for potential authors," said Winston Patrick Kuo, Harvard Medical School and Exosomes and Microvesicles editor. "Our goal is to remove access barriers to new, important research and globalize the scientific dialog. Through this new journal and its open access platform, we hope to provide the science community an international connection to cutting-edge research and potential new health solutions."

Research Categories Several categories of papers will be published, including original research articles, methods, review articles, hypothesis and opinions, letters to the Editors and meeting reports. Submissions are encouraged from all institutions and researchers working on topics related to extracellular vesicles, including:

  • Biogenesis of extracellular vesicles, both in eukaryotic and prokaryotic cells
  • Mechanisms of vesicle: cell interactions
  • Intercellular signaling
  • Intercellular traffic of proteins, nucleic acids and other macromolecules
  • Modulation of the extracellular matrix:
    • Roles of extracellular vesicles in normal physiological processes, including differentiation, development, immunity, tissue repair, stem cell biology, etc.
    • Roles of extracellular vesicles in disease, including cancer, diabetes, neurodegeneration, aging, HIV/AIDS, etc.
  • Virology and bacteriology
  • Biomarkers
  • Technical advances in vesicle purification and characterization
  • Design and production of cell derived vesicles
  • Design and production of synthetic vesicles
  • Use of extracellular vesicles in:
    • Diagnostics and companion diagnostics
    • Therapeutics delivery
    • Antigen presentation and vaccine development
    • Cell free regenerative medicine
    • Association with other synthetic nanoparticle for different scopes

About the American Society for Exosomes and Microvesicles The ASEMV is a non-profit scientific society dedicated to advancing exosome and microvesicle research, promoting interactions among exosome/microvesicle researchers, and educating scientists, funding agencies and policy makers about the biological, biomedical and biotechnological importance of secreted vesicles.

About InTech InTech is an Open Access publisher within the fields of Science, Technology and Medicine (STM). Established in 2004, the company is one of the earliest pioneers of open access and has since become one of the fastest growing publishers in the world today.

With offices located in Central Europe, InTech works with authors, editors and societies on a global scale to publish the latest advances in theories and application of some of the most exciting research areas in STM, all to be accessed freely online.

Media Contact: Ana Nodilo nodilo@intechopen.com +385 51 688 994



1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs